Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Membranous Expression and Prognostic Implications of Epidermal Growth Factor Receptor Protein in Human Renal Cell Cancer

AXEL S. MERSEBURGER, JÖRG HENNENLOTTER, PERIKLES SIMON, STEPHAN KRUCK, EVA KOCH, MARCUS HORSTMANN, URSULA KUEHS, RAINER KÜFER, ARNULF STENZL and MARKUS A. KUCZYK
Anticancer Research May 2005, 25 (3B) 1901-1907;
AXEL S. MERSEBURGER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JÖRG HENNENLOTTER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PERIKLES SIMON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEPHAN KRUCK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
EVA KOCH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARCUS HORSTMANN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
URSULA KUEHS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAINER KÜFER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ARNULF STENZL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARKUS A. KUCZYK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 25 no. 3B 1901-1907
PMID 
16158924

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received February 1, 2005
  • Accepted April 25, 2005
  • Published online May 1, 2005.

Copyright & Usage 
Copyright© 2005 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. AXEL S. MERSEBURGER1,
  2. JÖRG HENNENLOTTER1,
  3. PERIKLES SIMON2,
  4. STEPHAN KRUCK1,
  5. EVA KOCH1,
  6. MARCUS HORSTMANN1,
  7. URSULA KUEHS1,
  8. RAINER KÜFER3,
  9. ARNULF STENZL1 and
  10. MARKUS A. KUCZYK1
  1. 1Department of Urology, Eberhard Karls University Tuebingen, Hoppe-Seyler-Str. 3, 72076, Tuebingen
  2. 2Department of Medicine, Sec. of Sportmedicine, Eberhard Karls University Tuebingen, Silcherstr 5, 72076, Tuebingen
  3. 3Department of Urology, University of Ulm, Prittwitzstrasse 43, 89075, Ulm, Germany
  1. Correspondence to: Markus A. Kuczyk, M.D., Ph.D., Professor of Urology, Eberhard-Karls-University, Hoppe-Seyler-Str. 3, 72076 Tuebingen, Germany. Tel: +49 7071 29 86585, Fax: +49 7071 295092.

Statistics from Altmetric.com

Cited By...

  • 43 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 25, Issue 3B
1 May 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Membranous Expression and Prognostic Implications of Epidermal Growth Factor Receptor Protein in Human Renal Cell Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Membranous Expression and Prognostic Implications of Epidermal Growth Factor Receptor Protein in Human Renal Cell Cancer
AXEL S. MERSEBURGER, JÖRG HENNENLOTTER, PERIKLES SIMON, STEPHAN KRUCK, EVA KOCH, MARCUS HORSTMANN, URSULA KUEHS, RAINER KÜFER, ARNULF STENZL, MARKUS A. KUCZYK
Anticancer Research May 2005, 25 (3B) 1901-1907;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Membranous Expression and Prognostic Implications of Epidermal Growth Factor Receptor Protein in Human Renal Cell Cancer
AXEL S. MERSEBURGER, JÖRG HENNENLOTTER, PERIKLES SIMON, STEPHAN KRUCK, EVA KOCH, MARCUS HORSTMANN, URSULA KUEHS, RAINER KÜFER, ARNULF STENZL, MARKUS A. KUCZYK
Anticancer Research May 2005, 25 (3B) 1901-1907;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Targeting HIF2 in Clear Cell Renal Cell Carcinoma
  • Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma
  • Lapatinib Versus Hormone Therapy in Patients With Advanced Renal Cell Carcinoma: A Randomized Phase III Clinical Trial
  • Google Scholar

More in this TOC Section

  • CD133+ Lung Cancer Stem-like Cells Resist Plasma-activated Medium Through PRDX5-mediated Antioxidant Defense
  • Iodine-Hoechst Enhances X-ray Sensitivity of Cancer Cells Under Normal and Low Oxygen Conditions
  • Exploring SLC1A5 (ASCT2), SLC7A5, and SLC3A2 (LAT1) Genetic Variants in Colorectal Cancer: Implications for Prognosis and Personalized Care
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire